93 related articles for article (PubMed ID: 36975413)
21. Risk and Prognostic Factors for BRAF
Wei X; Wang X; Xiong J; Li C; Liao Y; Zhu Y; Mao J
Biomed Res Int; 2022; 2022():9959649. PubMed ID: 35647194
[TBL] [Abstract][Full Text] [Related]
22. Clinical application of the ultrasound-guided fine needle aspiration for thyroglobulin measurement to diagnose lymph node metastasis from differentiated thyroid carcinoma-literature review.
Jiang HJ; Hsiao PJ
Kaohsiung J Med Sci; 2020 Apr; 36(4):236-243. PubMed ID: 31909556
[TBL] [Abstract][Full Text] [Related]
23. Tumor-Infiltrating Immune Cell Landscapes in the Lymph Node Metastasis of Papillary Thyroid Cancer.
Amanullah M; Pan M; Lu K; Pan X; Lu Y; Luo D; Liu P
Curr Oncol; 2023 Feb; 30(3):2625-2641. PubMed ID: 36975413
[TBL] [Abstract][Full Text] [Related]
24. Identification of biomarkers associated with cervical lymph node metastasis in papillary thyroid carcinoma: Evidence from an integrated bioinformatic analysis.
Zhang Z; Zhao S; Wang K; Shang M; Chen Z; Yang H; Chen Y; Chen B
Clin Hemorheol Microcirc; 2021; 78(2):117-126. PubMed ID: 33554894
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic and prognostic value of tumor-infiltrating B cells in lymph node metastases of papillary thyroid carcinoma.
Yang Z; Yin L; Zeng Y; Li Y; Chen H; Yin S; Zhang F; Yang W
Virchows Arch; 2021 Nov; 479(5):947-959. PubMed ID: 34148127
[TBL] [Abstract][Full Text] [Related]
26. The role of molecular markers and tumor histological type in central lymph node metastasis of papillary thyroid carcinoma.
Paulson L; Shindo M; Schuff K; Corless C
Arch Otolaryngol Head Neck Surg; 2012 Jan; 138(1):44-9. PubMed ID: 22249628
[TBL] [Abstract][Full Text] [Related]
27. NONHSAT076754 aids ultrasonography in predicting lymph node metastasis and promotes migration and invasion of papillary thyroid cancer cells.
Xia S; Wang C; Ni X; Ni Z; Dong Y; Zhan W
Oncotarget; 2017 Jan; 8(2):2293-2306. PubMed ID: 27906682
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of the Impact of Hashimoto Thyroiditis on Papillary Thyroid Carcinoma Progression: Relationship with the Tumor Immune Microenvironment.
Sulaieva O; Chernenko O; Selesnov O; Nechay O; Maievskyi O; Falalyeyeva T; Kobyliak N; Tsyryuk O; Penchuk Y; Shapochka D
Endocrinol Metab (Seoul); 2020 Jun; 35(2):443-455. PubMed ID: 32615729
[TBL] [Abstract][Full Text] [Related]
29. Transcriptomic Analysis of Papillary Thyroid Cancer: A Focus on Immune-Subtyping, Oncogenic Fusion, and Recurrence.
Park SJ; Kang YE; Kim JH; Park JL; Kim SK; Baek SW; Chu IS; Yi S; Lee SE; Park YJ; Chung EJ; Kim JM; Ko HM; Kim JR; Jung SN; Won HR; Chang JW; Koo BS; Kim SY
Clin Exp Otorhinolaryngol; 2022 May; 15(2):183-193. PubMed ID: 35255661
[TBL] [Abstract][Full Text] [Related]
30. Profiling of immune features to predict immunotherapy efficacy.
Ye Y; Zhang Y; Yang N; Gao Q; Ding X; Kuang X; Bao R; Zhang Z; Sun C; Zhou B; Wang L; Hu Q; Lin C; Gao J; Lou Y; Lin SH; Diao L; Liu H; Chen X; Mills GB; Han L
Innovation (Camb); 2022 Jan; 3(1):100194. PubMed ID: 34977836
[TBL] [Abstract][Full Text] [Related]
31. Characterization of immune landscape in papillary thyroid cancer reveals distinct tumor immunogenicity and implications for immunotherapy.
Sun J; Shi R; Zhang X; Fang D; Rauch J; Lu S; Wang X; Käsmann L; Ma J; Belka C; Su C; Li M
Oncoimmunology; 2021; 10(1):e1964189. PubMed ID: 34513318
[TBL] [Abstract][Full Text] [Related]
32. BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer.
Tao Y; Wang F; Shen X; Zhu G; Liu R; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Zhao S; Wang Y; Xing M
J Clin Endocrinol Metab; 2021 Oct; 106(11):3228-3238. PubMed ID: 34273152
[TBL] [Abstract][Full Text] [Related]
33. Risk Factors for Recurrence of Follicular Thyroid Cancer: A Systematic Review.
Grønlund MP; Jensen JS; Hahn CH; Grønhøj C; Buchwald CV
Thyroid; 2021 Oct; 31(10):1523-1530. PubMed ID: 34102860
[No Abstract] [Full Text] [Related]
34. Systemic metastasis-targeted nanotherapeutic reinforces tumor surgical resection and chemotherapy.
Xu M; Hu K; Liu Y; Huang Y; Liu S; Chen Y; Wang D; Zhou S; Zhang Q; Mei N; Lu H; Li F; Gao X; Chen J
Nat Commun; 2021 May; 12(1):3187. PubMed ID: 34045459
[TBL] [Abstract][Full Text] [Related]
35. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
36. Cancer Statistics, 2021.
Siegel RL; Miller KD; Fuchs HE; Jemal A
CA Cancer J Clin; 2021 Jan; 71(1):7-33. PubMed ID: 33433946
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
